Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Trinity Biotech (TRIBY) -- Ignore unavailable to you. Want to Upgrade?

To: vegetarian who wrote (7850)	1/20/1998 2:51:00 PM
From: Ray	Respond to of 14328

I think you've hit the nail on the head. None of the other third-world agreement announcements mentioned specifics. The agreement with Warner Lambert at then end of 1995 (if I remember the date correctly) did mention sales expectations, but subsequent earnings announcements didn't fit what investors would have projected from the original announcement of the agreement. (It was only later on that we learned that the pregnancy test was being worked on and that revenues would be delayed.) Leaving investors in the dark about those basic aspects has had the effect of reducing the bounce in stock price that has come with each announcement of an agreement. Given all that history, it seems to me that only actual growth in revenue -- or a dramatic new contract announcment following FDA approval of the HIV Unigold -- or maybe be good summary judgement from Boston -- will move the stock significantly. Ray